Highland Capital Management, LLC Edwards Lifesciences Corp Transaction History

Highland Capital Management, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$69.28 - $93.38 $29,444 - $39,686	-425 Reduced 2.66%	15,548 $1.08 Million
Q2 2023 Aug 09, 2023	BUY	$81.41 - $94.33 $1.3 Million - $1.51 Million	15,973 New	15,973 $1.51 Million
Q4 2022 Feb 07, 2023	BUY	$68.3 - $87.44 $1.11 Million - $1.42 Million	16,265 New	16,265 $1.21 Million
Q1 2020 May 05, 2020	SELL	$52.41 - $81.0 $321,378 - $496,692	-6,132 Closed	0 $0
Q4 2019 Feb 05, 2020	SELL	$71.7 - $82.09 $462,608 - $529,644	-6,452 Closed	0 $0
Q3 2019 Nov 20, 2019	BUY	$61.55 - $75.43 $397,120 - $486,674	6,452 New	6,452 $1.42 Million
Q3 2018 Oct 17, 2018	SELL	$45.7 - $58.03 $136,186 - $172,929	-2,980 Closed	0 $0
Q2 2018 Jul 18, 2018	SELL	$42.45 - $51.3 $131,595 - $159,030	-3,100 Reduced 50.99%	2,980 $434,000
Q1 2018 Apr 16, 2018	BUY	$37.19 - $47.45 $226,115 - $288,496	6,080 New	6,080 $848,000

1,417

469M

2.44M

2.65M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $40.5B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Highland Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Highland Capital Management, LLC with notifications on news.